Results 211 to 220 of about 163,785 (367)

Heart Failure With Preserved Ejection Fraction: A Fascinating Journey. [PDF]

JACC Case Rep
O'Meara E.
europepmc   +1 more source

Association of Serum Triiodothyronine With B-Type Natriuretic Peptide and Severe Left Ventricular Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction [PDF]

, 2012
Senthil Selvaraj, Irwin Klein, Sara Danzi, Nausheen Akhter, Robert O. Bonow, Sanjiv J. Shah   +5 more
openalex   +1 more source

Myocardial inflammation is associated with impaired mitochondrial oxidative capacity in ischaemic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1246-1255, April 2025.
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger, Elric Zweck, Constanze Moos, Patrick Horn, Fabian Voß, Heinz‐Peter Schultheiss, Jacob Eifer Møller, Udo Boeken, Hug Aubin, Artur Lichtenberg, Malte Kelm, Michael Roden, Amin Polzin, Ralf Westenfeld, Julia Szendroedi, Daniel Scheiber   +15 more
wiley   +1 more source

Heart failure with preserved ejection fraction and obesity: emerging metabolic therapeutic strategies. [PDF]

Diabetol Metab Syndr
Zheng W, Qi Q, Li J, He C, Fan H.
europepmc   +1 more source

Angiotensin receptor blockers and outcomes in real‐world older patients with heart failure and preserved ejection fraction: a propensity‐matched inception cohort clinical effectiveness study [PDF]

, 2012
Kanan Patel, Gregg C. Fonarow, Dalane W. Kitzman, Inmaculada Aban, Thomas E. Love, Richard M. Allman, Mihai Gheorghiade, Ali Ahmed   +7 more
openalex   +1 more source

Outcome of heart failure with preserved ejection fraction in a population-based study.

New England Journal of Medicine, 2006
R. Bhatia, J. Tu, J. Tu, Douglas S. Lee, P. Austin, Jiming Fang, A. Haouzi, Y. Gong, Peter P. Liu, Peter P. Liu   +9 more
semanticscholar   +1 more source

Effects of sodium–glucose co‐transporter inhibitors on individual clinical endpoints and quality of life

ESC Heart Failure, Volume 12, Issue 2, Page 1271-1282, April 2025.
Effects of SGLTi on Individual Clinical Endpoints and Quality‐of‐Life: outcome from randomized data. Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk factors.
Jia Liao, Yang Chen, Zhiyu Ling, Helmut Pürerfellner, Martin Martinek, Michael Derndorfer, Johannes Niel, Ramin Ebrahimi, Matthias Heukäufer, Sarah Janschel, Davide Di Vece, Klaus Empen, Astrid Hummel, Bishwas Chamling, Piotr Futyma, Fahim Ebrahimi, Márcio G. Kiuchi, Shaowen Liu, Yuehui Yin, Alexandra Schratter, Willem‐Jan Acou, Philipp Sommer, Boris Schmidt, Julian K. R. Chun, Christian Meyer, Marcus Dörr, Christian Templin, Shaojie Chen   +27 more
wiley   +1 more source

Prognostic significance of unintentional weight loss in heart failure with preserved ejection fraction. [PDF]

Eur J Heart Fail
Ibe T, Demmer RT, Harada T, Doi S, Tada A, Naser JA, Reddy YNV, Borlaug BA.   +7 more
europepmc   +1 more source

FACTORS THAT PRECIPITATE HOSPITALIZATIONS FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION - CHARACTERISTICS AND IMPACT ON POST-DISCHARGE OUTCOME

, 2010
Dan Ruşinaru, Otilia Buiciuc, Franck Lévy, Marcel Peltier, Christophe Tribouilloy   +4 more
openalex   +1 more source

Reliability of Peak Exercise Testing in Patients With Heart Failure With Preserved Ejection Fraction [PDF]

, 2012
Jessica M. Scott, Mark J. Haykowsky, Joel Eggebeen, Timothy M. Morgan, Peter H. Brubaker, Dalane W. Kitzman   +5 more
openalex   +1 more source